A library of novel pyridylchalcones were synthesised and screened against Trypanosoma brucei rhodesiense. Eight were shown to have good activity with the most potent 8 having an IC 50 value of 0.29 µM. Cytotoxicity testing with human KB cells showed a good selectivity profile for this compound with a selectivity index of 47. Little activity was seen when the library was tested against Leishmania donovani. In conclusion, pyridylchalcones are promising leads in the development of novel compounds for the treatment of human African trypanosomiasis (HAT).
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Synthesis and antitrypanosomal activities of novel pyridyl-chalcones
Introduction
Human African trypanosomiasis (HAT), also known as sleeping sickness, is a parasitic disease transmitted by the bite of tsetse flies. It occurs in 36 countries in sub-Saharan Africa, where millions of people are at risk of infection [1] [2] [3] . HAT is caused by 2 subspecies of Trypanosoma brucei and exists as a chronic infection with T. b. gambiense or as an acute infection with T. b. rhodesiense. Untreated, both forms are usually fatal [1] [2] [3] .
There are two clinical stages in the progression of HAT. The first corresponds to the multiplication of the parasites in the blood and lymphatic system. The second occurs when these cross the blood-brain barrier to infect the central nervous system causing neurological symptoms to appear. Stage 1 can be treated with pentamidine and suramin whereas melarsoprol, eflornithine, and their combinations with nifurtimox are the only treatments for stage 2. All of these drugs suffer from serious drawbacks including low efficacy, severe toxic side effects and the need for parenteral administration [1] [2] [3] . With no vaccine available and limited therapeutic alternatives the continuing emergence of drug resistance is seen as a major public health problem [4] . An urgent need exists for the development of more effective, less toxic and orally available treatments for this neglected tropical disease.
Chalcones (1,3-diphenyl-2-propen-1-ones) are a major class of natural products often found in edible plants. They have received considerable attention due to their wide range of biological actions and have been used as a scaffold in the development of anticancer, antioxidant, antiangiogenic, and anti-inflammatory agents [5] . A number of natural and synthetic chalcones have been shown to possess anti-parasitic activities including licochalcone A 1, a natural prenylated chalcone isolated from liquorice root (Glycyrrhiza glabra), and a potent anti-leishmanial agent [6] . However, the therapeutic use of chalcones has been limited due to their poor bioavailability and rapid metabolic clearance from biological systems [7] . Nevertheless, hybrid molecules incorporating the chalcone moiety are emerging as promising leads for targeting Leishmania and Trypanosoma species [8] [9] [10] [11] . For example, the chalcone-benzoxaborole hybrid 2 gave 100% mouse survival rate and complete elimination of parasites in a T. b. brucei murine model [9] .
Pyridylchalcones, such as 3 and 4, have been found to exhibit both antimalarial and antileishmanial activity [6, 11, 12, 13] . However, there are no examples of them being tested against Trypanosoma brucei. With the antitrypanosomal activity of chalcone hybrids in mind [8] [9] [10] [11] , we were intrigued to determine whether pyridylchalcones would also be active against this target. It was anticipated that pyridyl analogues would exhibit the same low toxicity shown by compounds containing the chalcone nucleus but with improved bioavailability [14] . The introduction of a pyridine group will reduce the lipophilicity of the molecule and increase water solubility, both of which should ease formulation. In addition, lowering the lipophilicty of a chalcone and the inclusion of a heterocyclic A-ring has been associated with an increase in anti-parasitic activity [15] .
We report here the synthesis and in vitro evaluation of a series of novel pyridylchalcones against T. b. rhodesiense and L. donovani. Their cytotoxicity against human KB cells was also determined to establish their selectivity profile.
Chemistry
Attempts to prepare the 3-(3-pyridyl)chalcone 8 using standard Claisen-Schmidt conditions with 2 equivalents of aqueous sodium hydroxide in methanol yielded an unexpected result [16] . Instead of the desired chalcone, recrystallization from ethanol afforded the diketone 7 in 25% yield (Scheme 1). This product presumably results from conjugate addition of the enolate of 3-bromoacetophenone to the previously formed chalcone. Similar results were obtained when using 3-chloroacetophenone and 4-chloroacetophenone. To our knowledge this unusual reactivity has not previously been reported for 3-pyridinecarboxaldehyde 5, The addition of one equivalent of pyridine to these reactions was found to prevent this conjugate addition. This was thought to be due to the pyridine competing with the aldolate nitrogen for chelation of the metal ion in the intermediate. Unfortunately, this result was not repeated when one equivalent of pyridine was added to our reaction.
Bhagat et al report good yields of chalcone with all three isomers of pyridinecarboxaldehyde when reacted with 4-methoxyacetophenone and 10% lithium hydroxide monohydrate in ethanol [18] . Using these conditions, we obtained 8 in a disappointing yield of 39%. It was clear from TLC that 7 was still being formed during this reaction. This proved difficult to remove by recrystallization from ethanol, and column chromatography was required to obtain pure 8. In a bid to improve yields and simplify purification we investigated the use of potassium hydroxide as a catalyst in 1,4-dioxane. This couple has been found to give good yields of quinoline-2-one based chalcones which had proved difficult to prepare using other conditions [19] . However, with 1.6 equivalents of potassium hydroxide we again obtained a mixture of 8 and 7. Maintaining 1, 4-dioxane as the solvent but changing the base to lithium hydroxide monohydarate proved the solution to our problems with 8 being obtained in 80% yield after recrystallization from ethanol. TLC showed little or no diketone formation. This method proved suitable for the synthesis of a range of pyridylchalcones (Table 1 ) in high yield. The activity of our chalcones against T. b. rhodesiense (STIB900) was determined using the Alamar blue growth inhibition assay [20] . Their cytotoxicity against human KB cells was also obtained in vitro ( In view of the literature precedent [11, 12] and our above results with T. b. rhodesiense we decided to screen our compound library against Leishmania donovani [21] . Using HU3 intracellular amastigotes at 30 µM only 8, 9, 12 and 20 showed any activity, with 39.7, 13.8, Elemental analyses (C, H, N) was carried out by Warwick Analytical Services using a CE440 elemental analyser. Results were within ±0.4% of the theoretical values.
Results and discussion
1, 5-Di(3-bromophenyl)-3-(3-pyridyl)pentane-1,5-dione (7)
Sodium hydroxide solution (0. 
General method for chalcone synthesis
Lithium hydroxide monohydrate (0.63 g, 14.95 mmol) was added to a stirred solution of the appropriate aldehyde (9.35 mmol) and ketone (9.35 mmol) in 1,4-dioxane (2.5 mL) at RT.
Upon completion, as indicated by the formation of a precipitate and confirmed by TLC the reaction was quenched with water (30 mL). The resulting mixture was extracted with ethyl acetate (3x30 mL). The combined organic extracts were washed with brine (50 mL), dried (MgSO 4 ) and the solvent removed under vacuum. The crude product was purified by either recrystallization from ethanol or flash chromatography on silica gel.
(E)-1-(3-Bromophenyl)-3-(3-pyridinyl)prop-2-en-1-one (8)
Recrystallization from ethanol. Pale yellow crystals (80% 
(E)-1-(3-Bromophenyl)-3-(phenyl)prop-2-en-1-one (9)
Recrystallization from ethanol. Pale yellow crystals (67%). mp 82- 
(E)-1-(3-Methoxyphenyl)-3-(3-pyridinyl) prop-2-en-1-one (11)
Flash chromatography, 50% ethyl acetate: hexane. Light yellow solid (70% 
(E)-1-(4-Bromophenyl)-3-(3-pyridinyl)prop-2-en-1-one (12)
Recrystallization from ethanol. Fine off white crystals (80% 
(E)-1-(3-pyridinyl)-3-(3-pyridinyl)prop-2-en-1-one (24)
Recrystallization from ethanol. Pale yellow crystals (41% forms) with serial drug dilutions at 37°C for 72 h in 5% CO 2 . Each compound was tested in triplicate with 30 mg/ml the highest concentration of compound used and a 3-fold serial dilution was performed down to a suitable concentration to obtain an IC 50 value. Control wells were without drug and blanks were medium only. After 72 h of incubation the plates were inspected to assure growth in control wells and to determine the minimum inhibitory concentration (MIC). Subsequently, 20 µL of Alamar Blue™ was added to each well and the plates incubated for another 2-4 h. Plates were read on a Gemini Plate Reader (Molecular Devices) using an excitation wave length of 530 nm and an emission wave length of 580 nm (cut off 550 nm). IC 50 values were calculated using Prism © software. Pentamidine and melarsoprol were used as positive controls.
Toxicity on KB cells
KB cells, derived from a human carcinoma of the nasopharynx and typically used in assays for antineoplastic agents, were maintained in RPMI 1640 medium (Sigma, UK), 10% heat- 
